Page last updated: 2024-10-26

pentetic acid and Neutropenia

pentetic acid has been researched along with Neutropenia in 2 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.

Research Excerpts

ExcerptRelevanceReference
" Additionally, the in vivo biodistribution study clearly identified accumulations of G-CSF in the heart, liver, bone marrow, and urinary bladder, an indication of systemic absorption of G-CSF; its relative bioavailability was approximately 13."1.40Treatment of chemotherapy-induced neutropenia in a rat model by using multiple daily doses of oral administration of G-CSF-containing nanoparticles. ( Chen, CT; Chou, YC; Chuang, EY; Lin, KJ; Lin, PY; Mi, FL; Su, FY; Sung, HW; Wey, SP; Yen, TC, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Su, FY1
Chuang, EY1
Lin, PY1
Chou, YC1
Chen, CT1
Mi, FL1
Wey, SP1
Yen, TC1
Lin, KJ1
Sung, HW1
Forero, A1
Meredith, RF1
Khazaeli, MB1
Shen, S1
Grizzle, WE1
Carey, D1
Busby, E1
LoBuglio, AF1
Robert, F1

Trials

1 trial available for pentetic acid and Neutropenia

ArticleYear
Phase I study of 90Y-CC49 monoclonal antibody therapy in patients with advanced non-small cell lung cancer: effect of chelating agents and paclitaxel co-administration.
    Cancer biotherapy & radiopharmaceuticals, 2005, Volume: 20, Issue:5

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents

2005

Other Studies

1 other study available for pentetic acid and Neutropenia

ArticleYear
Treatment of chemotherapy-induced neutropenia in a rat model by using multiple daily doses of oral administration of G-CSF-containing nanoparticles.
    Biomaterials, 2014, Volume: 35, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Chitosan; Disease Models, Animal; Dose-Respons

2014